| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | TNYA | Common Stock | Sale | -$930 | -1.73K | -0.95% | $0.54 | 180K | Mar 10, 2025 | Direct | F1, F2, F3 |
| transaction | TNYA | Common Stock | Sale | -$2.19K | -4.07K | -2.26% | $0.54 | 176K | Mar 10, 2025 | Direct | F1, F2, F4 |
| transaction | TNYA | Common Stock | Sale | -$860 | -1.6K | -0.91% | $0.54 | 175K | Mar 10, 2025 | Direct | F2, F5, F6 |
| Id | Content |
|---|---|
| F1 | Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 15, 2023. |
| F2 | Represents the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $0.5080 to $0.5846. Reporting Person undertakes to provide Tenaya Therapeutics, Inc., any security holder of Tenaya Therapeutics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. |
| F3 | Includes 131,051 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units and 3,409 shares of common stock acquired pursuant to the Tenaya Therapeutics, Inc. 2021 Employee Stock Purchase Plan on December 10, 2024. |
| F4 | Includes 119,801 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |
| F5 | Shares sold to cover tax withholding obligations in connection with the vesting of restricted stock units awarded on February 23, 2024. |
| F6 | Includes 115,426 shares of Tenaya Therapeutics, Inc. common stock that will be issued to the Reporting Person upon vesting of restricted stock units. |